Abstract
Cardiometabolic effect of switching from an efavirenz-based therapy to a dolutegravir-based therapy on clinical and virological outcomes among people living with HIV at the Yaoundé Central Hospital
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have